The in vitro cytotoxicity results exhibited greater antiproliferative activity for the targeting NPs against the PSMA-positive androgen-sensitive human prostate cancer cells (LNCaP) after 48 and 72 h of incubation when compared with the non-targeting NPs [29]. This evidence concerns the gene FOLH1 and prostate carcinoma.